Skip to main content
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Lung Cancer
0
0.9
Otolaryngology
0
0.95
Small Cell Lung Cancer
0
0.98
Cancer
0
0.93
Non-Small Cell Lung Cancer
0
0.83
Skin Cancer
0
0.8
Hepatocellular Carcinoma
0
0.76
Toxicology
0
0.68
Intravenous
0
0.42
Chemotherapy
0
0.15
Cough
0
0.15
Dyspnea
0
0.15
Fatigue
0
0.15
Femoral
0
0.15
Food and Drug Administration (FDA)
0
0.15
Geriatrics
0
0.15
Immunotherapy
0
0.15
Lung
0
0.15
Melanoma
0
0.15
Pain
0
0.15
Pain Management
0
0.15
Platinum
0
0.15
Sarcoma
0
0.15
Specialty
Lead
score
Hematology-Oncology
1
1
Family Medicine/Primary Care
0
0.6
Internal Medicine
0
0.7
Pharmacist
0
0.5
Pulmonary Medicine
0
0.9
Dermatology
0
0.8
Edit Tags